arrow
罗

罗东华 (Dong-Hua Luo)

Shanghai University of Electric Power
H指数:22
被引数:1,536

个人简介

主任医师。2007/9-2010/6, 中山大学, 肿瘤学, 博士;2001/9-2003/6, 中山大学, 肿瘤学, 硕士;1996/9-2001/6, 中山医科大学, 临床医学, 学士。2024/1-至今, 中山大学, 肿瘤防治中心, 主任医师;2016/1-2023/12, 中山大学, 肿瘤防治中心, 副主任医师;2011/1-2011/7, 美国Van Andel研究所,访问学者;2010/7-2010/12, 美国范德堡大学放疗科, 访问学者;2006/1-2015/12, 中山大学, 肿瘤防治中心, 主治医师;2003/9-2005/12, 中山大学, 肿瘤防治中心, 住院医师。

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study

影像组学特征揭示了与再照射鼻咽癌的组织耐受性和生存率相关的多尺度肿瘤内异质性: 一项多中心研究

2023-11-2713
OAAI
Original Research Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
2023-11-016
PRE
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity- modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial
2023-11-016
OAAI
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients
2023-09-017
PRE
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial

Camrelizumab联合阿帕替尼治疗一线铂类耐药或PD-1抑制剂耐药复发/转移性鼻咽癌的单臂2期临床试验

2023-08-1413
OAAI
Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial
2021-12-2013
OAAI
A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
2021-06-0315
OAAI
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT
2021-01-0810
PREAI